Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor (1).
about
Granulocyte and granulocyte-macrophage colony stimulating factors for newly diagnosed patients with myelodysplastic syndromesColony stimulating factors for prevention of chemotherapy induced febrile neutropenia in children with acute lymphoblastic leukaemiaGranulocyte colony-stimulating factor receptor signaling involves the formation of a three-component complex with Lyn and Syk protein-tyrosine kinasesBiological response modifiers in cancerScience review: Cell membrane expression (connectivity) regulates neutrophil delivery, function and clearanceGranulocyte colony-stimulating factor-producing hepatocellular carcinoma with abrupt changesA three-arm phase III randomised trial assessing, in patients with extensive-disease small-cell lung cancer, accelerated chemotherapy with support of haematological growth factor or oral antibioticsEffectiveness of Granulocyte Colony-Stimulating Factor in Hospitalized Infants with Neutropenia.Neutrophil mobilization via plerixafor-mediated CXCR4 inhibition arises from lung demargination and blockade of neutrophil homing to the bone marrowProton MR spectroscopy of the lumbar spine in patients with glycogen storage disease type Ib.The efficacy of recombinant TPO in murine And nonhuman primate models for myelosuppression and stem cell transplantation.Pharmacokinetics and adverse events following 5-day repeated administration of lenograstim, a recombinant human granulocyte colony-stimulating factor, in healthy subjects.Autologous blood stem cell transplantation in hematological malignancies.The efficacy of recombinant thrombopoietin in murine and nonhuman primate models for radiation-induced myelosuppression and stem cell transplantation.Are clozapine patients at risk for blood dyscrasias with concomitant tamiflu use?Alcohol abuse and pulmonary disease.Modulation of neutrophil function in host defense against disseminated Candida albicans infection in mice.Current evidence for the induction of autoimmune rheumatic manifestations by cytokine therapy.Recombinant murine granulocyte-macrophage colony-stimulating factor modulates the course of pulmonary histoplasmosis in immunocompetent and immunodeficient mice.Rasayanas: evidence for the concept of prevention of diseases.Pulmonary alveolar proteinosis: progress in the first 44 years.Ligand-independent toll-like receptor signals generated by ectopic overexpression of MyD88 generate local and systemic antitumor immunityAdjunctive immune therapy for fungal infections.Heparin binding protein in patients with acute respiratory failure treated with granulocyte colony-stimulating factor (filgrastim)--a prospective, placebo-controlled, double-blind study.Granulocyte colony-stimulating factor-producing carcinoma of unknown primary site.A standardized blood test for the routine clinical diagnosis of impaired GM-CSF signaling using flow cytometry.Cytoplasmic phospholipase A2 translocates to membrane fraction in human neutrophils activated by stimuli that phosphorylate mitogen-activated protein kinase.The effect of granulocyte-colony stimulating factor on rotator cuff healing after injury and repair.Epidemiology of nosocomial fungal infections.Cytokines and progenitor cells of granulocytopoiesis in peripheral blood of patients with bacterial infections.Immunoregulatory mechanisms of T-cell-dependent shock induced by a bacterial superantigen in mice.Gene and cell therapy for pancreatic cancer.Effect of granulocyte-macrophage colony-stimulating factor in experimental visceral leishmaniasisEffects of granulocyte and granulocyte-macrophage colony-stimulating factors in a neutropenic murine model of trichosporonosis.MR imaging of therapy-induced changes of bone marrow.Development of secreted proteins as biotherapeutic agents.Efficacy of granulocyte colony-stimulating factor and RU-40555 in combination with clarithromycin against Mycobacterium avium complex infection in C57BL/6 mice.Adjunctive granulocyte colony-stimulating factor therapy for diabetic foot infections.rhGM-CSF ameliorates neutropenia in patients with malignant glioma treated with BCNU.Intratibial injection of an anti-doxorubicin monoclonal antibody prevents drug-induced myelotoxicity in mice.
P2860
Q24186133-C9DC39BF-7195-4EC9-8944-4E39C8BE6C97Q24250081-6E12E407-6FDA-49D2-A8E9-7EBBC7948CF1Q24563242-6B6FC2EB-C66B-477F-8445-EBB9D22C1B4DQ24685049-1401403A-F1E4-4BBA-83EB-F318032963B1Q24795355-454945DC-7B66-4EDD-9FD9-D2631795C404Q28078127-8832D8D2-93DC-4197-ABBE-9E1E3D5227A0Q28364853-77FF3334-9017-4E93-B1C0-84650EDF6F70Q30275884-DD14F2D3-BD40-47A8-94C0-40A3418CC1BEQ30552565-95564824-406A-42BF-85EF-FEF67C4F5137Q30667103-48E13BE3-0045-49CC-8B82-F69F9829D8CEQ33334361-8E95876A-09FE-43DB-BB8F-FD1C3278E969Q33335293-55F2C4AE-08D1-4B53-8FE5-2C830CEDD2ABQ33491628-08625CA1-D696-4CA5-B53A-18268CFDA72AQ33504493-061E0AAB-B410-4648-B35F-2E6355ADB39AQ33570619-60CC688F-3A79-463C-B614-1C833194AAF5Q33755478-C2CDB977-5C21-41E7-BDA2-42A07DB0499DQ33780929-5929E31A-0039-4F40-9C50-9BD002D94AFEQ33973488-A798F20F-0778-44B0-AD99-064F5F186068Q33980985-4395F8BF-B6F9-47AA-A387-88C2A8C696B3Q34133599-C1398AEA-97AA-4334-9722-C44A2AB42A35Q34139014-1FAEFE55-3B56-417D-BAB7-B703CC4BB677Q34153811-DA9DF618-67A3-4CA8-96AB-D456A5FA77DAQ34350401-1BEBB562-3ABD-4E89-A3EA-92DF39E8E50FQ34567545-1E1B3320-891B-4696-81DA-E4A3023336C1Q35066926-4B363AFD-EBF6-45F0-A0D1-A64CE3C1F2D0Q35078403-89C58789-25BD-46DE-AEE8-FA6D2E9E0089Q35157700-770909A6-B8B8-4E2C-B73E-B3AE48ED9D31Q35268244-651D8F1B-58E2-42F2-878C-21E07AD56FCCQ35372424-EE14C0E2-D5F4-4ED5-85F7-E1331AA79DF3Q35378321-83E0C489-CE48-4EA0-9101-3C6DA8C7B243Q35514832-9843DDAE-9445-4863-B456-E3FDD0000D83Q35541787-CFF8F584-FEC7-4218-8F72-5E6A09BE30C8Q35553326-23A97143-556C-43A5-90F0-43EC345A23B4Q35553643-E33C5F19-D655-4107-82A3-36E589AB74A8Q35633828-7692B1B2-9D59-4B6E-8EBD-AFD4693D6B8EQ35753538-738EC2B1-9003-476C-B370-468E77624C50Q35811091-551C7E6E-032F-407E-A5AE-F23E90CA2028Q35923147-C43AD64A-BC3E-45AE-B325-21D4FE3F931EQ35978279-3752E40B-F6E6-45A8-9CBE-04DD7D0A0052Q36116244-F3130471-66B2-4B2C-886C-A0A14D03BBBD
P2860
Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor (1).
description
1992 nî lūn-bûn
@nan
1992 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
name
Granulocyte colony-stimulating ...... colony-stimulating factor (1).
@ast
Granulocyte colony-stimulating ...... colony-stimulating factor (1).
@en
type
label
Granulocyte colony-stimulating ...... colony-stimulating factor (1).
@ast
Granulocyte colony-stimulating ...... colony-stimulating factor (1).
@en
prefLabel
Granulocyte colony-stimulating ...... colony-stimulating factor (1).
@ast
Granulocyte colony-stimulating ...... colony-stimulating factor (1).
@en
P1476
Granulocyte colony-stimulating ...... colony-stimulating factor (1).
@en
P2093
Burgess AW
Lieschke GJ
P356
10.1056/NEJM199207023270106
P407
P577
1992-07-01T00:00:00Z